• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于外泌体的天然产物在癌症治疗中的递送

Exosome-Based Delivery of Natural Products in Cancer Therapy.

作者信息

Song Hang, Liu Bin, Dong Bin, Xu Jing, Zhou Hui, Na Sha, Liu Yanyan, Pan Yunxia, Chen Fengyuan, Li Lu, Wang Jinghui

机构信息

Department of Biochemistry and Molecular Biology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China.

Institute of Integrated Chinese and Western Medicine, Anhui Academy of Chinese Medicine, Hefei, China.

出版信息

Front Cell Dev Biol. 2021 Mar 2;9:650426. doi: 10.3389/fcell.2021.650426. eCollection 2021.

DOI:10.3389/fcell.2021.650426
PMID:33738290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7960777/
Abstract

A rapidly growing research evidence has begun to shed light on the potential application of exosome, which modulates intercellular communications. As donor cell released vesicles, exosomes could play roles as a regulator of cellular behaviors in up-taken cells, as well as a delivery carrier of drugs for targeted cells. Natural product is an invaluable drug resources and it is used widely as therapeutic agents in cancers. This review summarizes the most recent advances in exosomes as natural product delivery carriers in cancer therapy from the following aspects: composition of exosomes, biogenesis of exosomes, and its functions in cancers. The main focus is the advantages and applications of exosomes for drug delivery in cancer therapy. This review also summarizes the isolation and application of exosomes as delivery carriers of natural products in cancer therapy. The recent progress and challenges of using exosomes as drug delivery vehicles for five representative anti-cancer natural products including paclitaxel, curcumin, doxorubicin, celastrol, and β-Elemene. Based on the discussion on the current knowledge about exosomes as delivery vehicles for drugs and natural compounds to the targeted site, this review delineates the landscape of the recent research, challenges, trends and prospects in exosomes as delivery vehicles for drugs and natural compounds for cancer treatment.

摘要

越来越多的研究证据开始揭示外泌体的潜在应用,外泌体可调节细胞间通讯。作为供体细胞释放的囊泡,外泌体可作为摄取细胞中细胞行为的调节剂,以及靶向细胞的药物递送载体。天然产物是一种宝贵的药物资源,在癌症治疗中被广泛用作治疗剂。本文综述了外泌体作为天然产物递送载体在癌症治疗中的最新进展,包括外泌体的组成、生物发生及其在癌症中的功能。主要关注外泌体在癌症治疗中药物递送的优势和应用。本文还总结了外泌体作为天然产物递送载体在癌症治疗中的分离和应用。使用外泌体作为包括紫杉醇、姜黄素、阿霉素、雷公藤红素和β-榄香烯在内的五种代表性抗癌天然产物的药物递送载体的最新进展和挑战。基于对外泌体作为药物和天然化合物递送载体将其递送至靶位点的现有知识的讨论,本文描绘了外泌体作为癌症治疗药物和天然化合物递送载体的最新研究、挑战、趋势和前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ac/7960777/3a470b2a8256/fcell-09-650426-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ac/7960777/b2faf2f73a01/fcell-09-650426-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ac/7960777/93514a86908c/fcell-09-650426-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ac/7960777/3a470b2a8256/fcell-09-650426-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ac/7960777/b2faf2f73a01/fcell-09-650426-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ac/7960777/93514a86908c/fcell-09-650426-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ac/7960777/3a470b2a8256/fcell-09-650426-g003.jpg

相似文献

1
Exosome-Based Delivery of Natural Products in Cancer Therapy.基于外泌体的天然产物在癌症治疗中的递送
Front Cell Dev Biol. 2021 Mar 2;9:650426. doi: 10.3389/fcell.2021.650426. eCollection 2021.
2
Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds.外泌体的生物发生、生物活性和功能作为天然化合物的新型递药系统。
Biotechnol Adv. 2018 Jan-Feb;36(1):328-334. doi: 10.1016/j.biotechadv.2017.12.010. Epub 2017 Dec 14.
3
A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.外泌体作为药物递送载体——用于靶向癌症治疗的内源性纳米载体的全面概述。
Biochim Biophys Acta. 2014 Aug;1846(1):75-87. doi: 10.1016/j.bbcan.2014.04.005. Epub 2014 Apr 18.
4
From structures to functions: insights into exosomes as promising drug delivery vehicles.从结构到功能:深入了解外泌体作为有前途的药物传递载体。
Biomater Sci. 2016 May 24;4(6):910-21. doi: 10.1039/c5bm00583c.
5
Current Perspectives of Exosomes as Therapeutic Targets and Drug Delivery Vehicles for Pancreatic Cancer.外泌体作为胰腺癌治疗靶点和药物递送载体的当前观点
Crit Rev Oncog. 2019;24(2):179-190. doi: 10.1615/CritRevOncog.2019031202.
6
Exosomes: Diagnostic and Therapeutic Implications in Cancer.外泌体:在癌症中的诊断和治疗意义
Pharmaceutics. 2023 May 11;15(5):1465. doi: 10.3390/pharmaceutics15051465.
7
Exosome: a significant nano-scale drug delivery carrier.外泌体:一种重要的纳米级药物递送载体。
J Mater Chem B. 2020 Sep 14;8(34):7591-7608. doi: 10.1039/d0tb01499k. Epub 2020 Jul 22.
8
Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application.基于外泌体的肿瘤治疗递送策略:修饰、加载和临床应用的最新进展。
J Nanobiotechnology. 2024 Jan 28;22(1):41. doi: 10.1186/s12951-024-02298-7.
9
New advances in exosome-based targeted drug delivery systems.基于外泌体的靶向药物传递系统的新进展。
Crit Rev Oncol Hematol. 2022 Apr;172:103628. doi: 10.1016/j.critrevonc.2022.103628. Epub 2022 Feb 18.
10
Tumor-targeted exosomes for delivery of anticancer drugs.肿瘤靶向外泌体递送抗癌药物。
Cancer Lett. 2023 Apr 1;558:216093. doi: 10.1016/j.canlet.2023.216093. Epub 2023 Feb 21.

引用本文的文献

1
Exosome-Based Therapeutics: A Natural Solution to Overcoming the Blood-Brain Barrier in Neurodegenerative Diseases.基于外泌体的疗法:克服神经退行性疾病中血脑屏障的天然解决方案。
MedComm (2020). 2025 Sep 12;6(9):e70386. doi: 10.1002/mco2.70386. eCollection 2025 Sep.
2
Loading of Enzymatic Cargos into Extracellular Vesicles Derived from Lung Cancer Cells.将酶类货物装载到源自肺癌细胞的细胞外囊泡中。
Int J Nanomedicine. 2025 Aug 15;20:9931-9944. doi: 10.2147/IJN.S528193. eCollection 2025.
3
Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases.

本文引用的文献

1
Cow Milk and Intestinal Epithelial Cell-derived Extracellular Vesicles as Systems for Enhancing Oral Drug Delivery.牛奶和肠上皮细胞衍生的细胞外囊泡作为增强口服药物递送的系统。
Pharmaceutics. 2020 Mar 4;12(3):226. doi: 10.3390/pharmaceutics12030226.
2
A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro.一种由阿霉素和间充质干细胞来源的外泌体组成的纳米药物,用于体外骨肉瘤治疗。
Int J Nanomedicine. 2019 Nov 1;14:8603-8610. doi: 10.2147/IJN.S218988. eCollection 2019.
3
Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy.
用于治疗眼部疾病的基于纳米医学的眼科药物递送系统
Int J Nanomedicine. 2025 Jul 21;20:9221-9249. doi: 10.2147/IJN.S532074. eCollection 2025.
4
Recent advances in engineered exosome-based therapies for ocular vascular disease.基于工程外泌体的眼部血管疾病治疗的最新进展
J Nanobiotechnology. 2025 Jul 19;23(1):526. doi: 10.1186/s12951-025-03589-3.
5
Exosomal delivery of non-coding RNAs: a pathway to apoptosis regulation in lung cancer.外泌体介导的非编码RNA传递:肺癌细胞凋亡调控途径
Med Oncol. 2025 Jul 1;42(8):307. doi: 10.1007/s12032-025-02852-9.
6
Extracellular vesicles as vital players in drug delivery: a focus on clinical disease treatment.细胞外囊泡作为药物递送的关键参与者:聚焦临床疾病治疗
Front Bioeng Biotechnol. 2025 May 14;13:1600227. doi: 10.3389/fbioe.2025.1600227. eCollection 2025.
7
Characterization and Specific Detection of -Derived Extracellular Vesicles Using Anti-p40-Modified Au Thin Film.使用抗p40修饰的金薄膜对源自 的细胞外囊泡进行表征和特异性检测。 (注:原文中“-Derived”处有信息缺失)
Pharmaceutics. 2025 May 16;17(5):654. doi: 10.3390/pharmaceutics17050654.
8
Extracellular Vesicle-Based Drug Delivery Systems in Cancer Therapy.基于细胞外囊泡的癌症治疗药物递送系统
Int J Mol Sci. 2025 May 19;26(10):4835. doi: 10.3390/ijms26104835.
9
Targeting breast cancer: the promise of phage-based nanomedicines.靶向乳腺癌:基于噬菌体的纳米药物的前景。
Breast Cancer Res Treat. 2025 Jun;211(3):561-580. doi: 10.1007/s10549-025-07696-5. Epub 2025 Apr 17.
10
The potential of exosomes in regenerative medicine and in the diagnosis and therapies of neurodegenerative diseases and cancer.外泌体在再生医学以及神经退行性疾病和癌症的诊断与治疗中的潜力。
Front Med (Lausanne). 2025 Mar 13;12:1539714. doi: 10.3389/fmed.2025.1539714. eCollection 2025.
功能外泌体介导的多柔比星和疏水性修饰的 microRNA 159 共递送用于三阴性乳腺癌治疗。
J Nanobiotechnology. 2019 Sep 3;17(1):93. doi: 10.1186/s12951-019-0526-7.
4
Targeted delivery of doxorubicin to HER2 positive tumor models.阿霉素靶向递送至 HER2 阳性肿瘤模型。
Int J Nanomedicine. 2019 Jul 24;14:5679-5690. doi: 10.2147/IJN.S210731. eCollection 2019.
5
Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques.载紫杉醇的脑胶质瘤细胞来源外泌体:两种加载技术的比较研究。
Daru. 2019 Dec;27(2):533-539. doi: 10.1007/s40199-019-00280-5. Epub 2019 Jul 17.
6
Insights on the Multifunctional Activities of Magnolol.厚朴酚多功能活性的研究进展。
Biomed Res Int. 2019 May 23;2019:1847130. doi: 10.1155/2019/1847130. eCollection 2019.
7
The role of tumor-derived exosomes in epithelial mesenchymal transition (EMT).肿瘤来源的外泌体在上皮-间质转化(EMT)中的作用。
Transl Cancer Res. 2017 Feb;6(Suppl 1):S90-S92. doi: 10.21037/tcr.2017.02.13.
8
Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation.M1 极化巨噬细胞来源的外泌体通过激活巨噬细胞介导的炎症增强紫杉醇的抗肿瘤活性。
Theranostics. 2019 Feb 28;9(6):1714-1727. doi: 10.7150/thno.30716. eCollection 2019.
9
Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance.外泌体:在癌症转移和耐药中的组成、发生机制和作用。
Mol Cancer. 2019 Apr 2;18(1):75. doi: 10.1186/s12943-019-0991-5.
10
Embryonic Stem Cells-Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy.具有靶向特性的胚胎干细胞衍生外泌体作为胶质母细胞瘤治疗的化疗药物递送载体
Adv Sci (Weinh). 2019 Feb 1;6(6):1801899. doi: 10.1002/advs.201801899. eCollection 2019 Mar 20.